Business ❯Pharmaceuticals

Manufacturing

Investment Job Creation Domestic Production Safety Regulations Labor Relations Supply Chain Production Issues Production Sites Environmental Issues Tariffs

Sanofi Announces $20 Billion U.S. Investment to Expand Manufacturing and R&D

The French pharmaceutical giant's move aligns with industry efforts to counter trade policy uncertainties and bolster domestic supply chains.

Roche Commits $700M to North Carolina Biologics Facility as Part of $50B U.S. Expansion

AstraZeneca Reports Q1 Growth and Expands US Investments Amid Regulatory Challenges

Novartis Confirms $23 Billion U.S. Investment with Major Expansion Plans

Novartis Announces $23 Billion U.S. Expansion with New Plants and R&D Hub

Sanofi Employees Protest Planned Sale of Amilly Factory

Sanofi Indicted Over Toxic Emissions at Mourenx Plant

Pfizer Considers Relocating Overseas Manufacturing to U.S. Facilities

Eli Lilly Announces $27 Billion Investment in U.S. Manufacturing Expansion

Eli Lilly Announces $3 Billion Wisconsin Manufacturing Expansion

French Government Seeks Job Guarantees in Sanofi's Doliprane Sale

Eli Lilly Invests $1.8 Billion to Expand Drug Production in Ireland

Eli Lilly Invests $9 Billion to Boost Production of Weight Loss Drugs

Bristol Myers Squibb Acquires RayzeBio for $4.1 Billion